Maryland, Virginia Medical Facilities Respond To Meningitis Outbreak | WAMU 88.5 - American University Radio

WAMU 88.5 : News

Filed Under:

Maryland, Virginia Medical Facilities Respond To Meningitis Outbreak

Play associated audio

Several Maryland and Virginia medical facilities are contacting hundreds of patients who may have received injections of a tainted drug that has sickened 31 people in five states.

Seven clinics in Maryland and two in southwest Virginia issued steroid injections that may contain a fungus that causes meningitis. So far, one person has died in Maryland and another in Virginia. Between the two states, there have been six reported cases.

Dr. David Trump with the Virginia Department of Health expects that number to rise.

"We expect that as we continue with the contact information, we may hear about other individuals who are ill and expect the numbers in Virginia and across the nation to change in the next several days to several weeks," says Trump.

The government is warning doctors and hospitals not to use any product from New England Compounding Center in Massachusetts, the specialty pharmacy that made the steroid suspected in the meningitis outbreak.

NPR

Smithsonian In Talks Over London Outpost — Its First Overseas

If negotiations are successful, the Smithsonian would join other attractions at the site of London's Olympic Park.
NPR

Why Dump Treated Wastewater When You Could Make Beer With It?

An Oregon company has developed a high-tech process for turning sewage into pure drinking water. Now it's asking the state for permission to give its recycled water to a group of home brewers.
NPR

White House Won't Seek To End 529 College Tax Break

All 50 states and the District of Columbia sponsor 529 plans. Critics had called the proposal to limit them a tax hike on the middle class.
NPR

Yahoo Plans To Spin Off Remaining Stake In Alibaba

Yahoo has announced it will spin off its 15 percent stake in the Chinese e-commerce company Alibaba. Shareholders had been waiting for that decision. The move needs regulatory approval.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.